Jeffrey G Supko

Massachusetts General Hospital

$3,480,570

Attributed

$3,480,570

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $270.5K · FY2005–21

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$3,480,570 · 3

By mechanism

P30$2,546,414 · 2

U01$934,156 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Harland S Winter$1,653,812
Arnab Chakravarti$9,324,533
Nabeel Bardeesy$18,920,034
David Tsai Ting$4,336,400
Benjamin Greenbaum$3,266,793

Others in their field

Top investigators on “Cancer Therapy”

David Heimbrook · Leidos Biomedical Research, Inc.$366,127,178
Norman Wolmark · Nsabp Foundation, Inc.$292,963,206
Gregory H Reaman · National Childhood Cancer Foundation$271,061,526
Peter C Adamson · National Childhood Cancer Foundation$269,808,480
Charles A Coltman · Southwest Oncology Group$178,303,465
Sudhir Raju · Ctis, Inc.$162,436,462

Research focus

Cancer TherapyDesignEvaluationPharmaceutical PreparationsDrug KineticsCancer CenterAnalytical MethodChemotherapeutic AgentToxic EffectBiologicalResearch Clinical TestingLiquid SubstanceInvestigationDana-Farber Cancer InstituteResearch PersonnelResourcesPre-ClinicalPreclinical EvaluationModificationCancer PharmacologyPharmacodynamicsServicesTreatment ProtocolsValidation